Lonza Group Ag Price to Book Ratio 2012-2024 | LZAGY

Historical price to book ratio values for Lonza Group Ag (LZAGY) over the last 10 years. The current price to book ratio for Lonza Group Ag as of May 02, 2025 is 4.83.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lonza Group Ag Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-05-01 71.34 0.00
2024-12-31 58.78 0.00
2023-12-31 41.69 0.00
2023-06-30 59.15 0.00
2022-12-31 48.30 0.00
2022-06-30 52.44 0.00
2021-12-31 81.98 0.00
2021-06-30 69.58 0.00
2020-12-31 62.79 0.00
2020-06-30 51.51 0.00
2019-12-31 35.48 0.00
2019-06-30 32.86 0.00
2018-12-31 24.91 0.00
2018-06-30 25.58 0.00
2017-12-31 25.75 0.00
2017-06-30 20.63 0.00
2016-12-31 14.04 0.00
2016-06-30 13.39 0.00
2015-12-31 12.97 0.00
2015-06-30 10.64 0.00
2014-12-31 8.79 0.00
2014-06-30 8.48 0.00
2013-12-31 7.21 0.00
2013-06-30 5.70 0.00
2012-12-31 3.93 0.00
2012-06-30 2.91 0.00
2011-12-31 4.10 0.00
2011-06-30 5.39 0.00
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $51.526B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $227.710B 27.38
Boston Scientific (BSX) US $152.625B 38.22
Stryker (SYK) US $142.748B 29.85
EssilorLuxottica (ESLOY) FR $131.899B 0.00
Medtronic (MDT) IE $107.169B 15.65
Haleon (HLN) GB $46.608B 26.49
ResMed (RMD) US $34.676B 26.05
GE HealthCare Technologies (GEHC) US $30.985B 14.71
Agilent Technologies (A) US $30.352B 20.05
Terumo (TRUMY) JP $28.456B 0.00
Koninklijke Philips (PHG) NL $23.480B 16.76
Zimmer Biomet Holdings (ZBH) US $20.144B 12.73
Insulet (PODD) US $17.608B 75.15
Baxter (BAX) US $15.731B 11.75
Smith & Nephew SNATS (SNN) GB $12.359B 0.00
Sunny Optical Technology (SNPTF) CN $9.032B 0.00
Demant (WILYY) DK $7.600B 0.00
Lantheus Holdings (LNTH) US $7.253B 17.83
Bio-Rad Laboratories (BIO) US $6.735B 22.77
Prestige Consumer Healthcare (PBH) US $4.074B 19.44
Shandong Weigao Medical Polymer (SHWGF) CN $3.459B 0.00
Perrigo (PRGO) IE $3.448B 9.87
ICU Medical (ICUI) US $3.371B 28.72
Haemonetics (HAE) US $3.164B 14.89
Envista Holdings (NVST) US $2.769B 23.01
LeMaitre Vascular (LMAT) US $2.039B 45.58
GN Store Nord (GNNDY) DK $1.930B 15.99
QuidelOrtho (QDEL) US $1.881B 15.75
AtriCure (ATRC) US $1.450B 0.00
Green Thumb Industries (GTBIF) US $1.325B 20.87
Kestra Medical Technologies (KMTS) US $1.179B 0.00
BioLife Solutions (BLFS) US $1.169B 0.00
AdaptHealth (AHCO) US $1.146B 11.04
Neogen (NEOG) US $1.118B 14.31
InMode (INMD) IL $1.023B 9.36
Evolus (EOLS) US $0.761B 0.00
Phibro Animal Health (PAHC) US $0.753B 11.55
Curaleaf Holdings (CURLF) CA $0.649B 0.00
CeriBell (CBLL) US $0.587B 0.00
Capricor Therapeutics (CAPR) US $0.582B 0.00
Owens & Minor (OMI) US $0.538B 4.59
Valneva SE (VALN) FR $0.534B 0.00
Maravai LifeSciences Holdings (MRVI) US $0.516B 0.00
Tilray Brands (TLRY) CA $0.489B 0.00
Cresco Labs (CRLBF) US $0.446B 0.00
Omeros (OMER) US $0.409B 0.00
Surmodics (SRDX) US $0.398B 0.00
SNDL (SNDL) CA $0.371B 0.00
SEMPERIT AG HLD (SEIGY) AT $0.350B 0.00
VAREX IMAGING (VREX) US $0.346B 14.98
Sanara MedTech (SMTI) US $0.287B 0.00
Verano Holdings (VRNOF) US $0.280B 0.00
Viemed Healthcare (VMD) US $0.279B 25.21
Aurora Cannabis (ACB) CA $0.267B 47.50
Canopy Growth (CGC) CA $0.259B 0.00
ZimVie (ZIMV) US $0.252B 15.07
Sanuwave Health (SNWV) US $0.249B 0.00
Cerus (CERS) US $0.249B 0.00
OraSure Technologies (OSUR) US $0.228B 0.00
Quanterix (QTRX) US $0.224B 0.00
High Tide (HITI) CA $0.194B 0.00
Biote (BTMD) US $0.179B 4.09
Utah Medical Products (UTMD) US $0.171B 13.81
Brainsway (BWAY) IL $0.166B 51.82
TriSalus Life Sciences (TLSI) US $0.164B 0.00
FitLife Brands (FTLF) US $0.144B 17.77
Organigram Global (OGI) CA $0.144B 0.00
Jin Medical (ZJYL) CN $0.125B 0.00
Agape ATP (ATPC) $0.117B 0.00
TerrAscend (TSNDF) CA $0.114B 0.00
Exagen (XGN) US $0.111B 0.00
MacroGenics (MGNX) US $0.106B 0.00
Oramed Pharmaceuticals (ORMP) US $0.093B 0.00
Quipt Home Medical (QIPT) US $0.092B 0.00
Veru (VERU) US $0.077B 0.00
Fonar (FONR) US $0.076B 10.70
Jushi Holdings (JUSHF) US $0.076B 0.00
InterCure (INCR) IL $0.071B 0.00
Cytosorbents (CTSO) US $0.063B 0.00
United Health Products (UEEC) US $0.062B 0.00
Zynex (ZYXI) US $0.061B 0.00
ImmuCell (ICCC) US $0.048B 0.00
Modular Medical (MODD) US $0.042B 0.00
Apyx Medical (APYX) US $0.040B 0.00
Safety Shot (SHOT) US $0.039B 0.00
United-Guardian (UG) US $0.037B 11.41
Rockwell Medical (RMTI) US $0.037B 54.00
Nephros (NEPH) US $0.019B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) IE $0.014B 0.00
Cellectar Biosciences (CLRB) US $0.012B 0.00
Flora Growth (FLGC) US $0.012B 0.00
Allurion Technologies (ALUR) US $0.011B 0.00
NeuroMetrix (NURO) US $0.009B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.004B 0.00
Senestech (SNES) US $0.004B 0.00
IM Cannabis (IMCC) CA $0.004B 0.00
Akanda (AKAN) GB $0.002B 0.00
Sharps Technology (STSS) US $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00